Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.67 USD | -2.65% |
|
-13.85% | -11.35% |
01/07 | Relmada Therapeutics, Inc.(NasdaqGS:RLMD) added to Russell Microcap Growth Index | CI |
01/07 | Relmada Therapeutics, Inc.(NasdaqGS:RLMD) added to Russell 3000E Growth Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.35% | 11Cr | |
+19.10% | 13TCr | |
+22.74% | 12TCr | |
+23.26% | 2.79TCr | |
-19.26% | 2.1TCr | |
-15.13% | 1.69TCr | |
-14.38% | 1.62TCr | |
+9.37% | 1.48TCr | |
-46.10% | 1.48TCr | |
+50.47% | 1.41TCr |
- Stock Market
- Equities
- RLMD Stock
- News Relmada Therapeutics, Inc.
- Transcript : Relmada Therapeutics, Inc., Q1 2022 Earnings Call, May 05, 2022